Galenicum

Galenicum was founded in Barcelona in 2003 with the mission of improving the quality and affordability of pharmaceutical products. Galenicum is continuing its adventure to become a global specialty pharmaceutical company, bringing further innovation to products in the years to come.

As of January 2021 Pharma Solution has become Galenicum agent and distributor in the United Arab Emirates. The first two products of many that will be marketed by Pharma Solution are set to be launched in the first quarter of 2021. Products are

  • Dutasvitae (Dutasteride) 0.5mg Capsules for moderate to severe symptoms of benign prostatic hyperplasia (BPH).
  • Tigevitae (Tigecycline) 50mg/5ml Vial Powder for Solution for Infusion Broad-spectrum antibiotic

S. No.

Product Name

Therapeutic Area

1

Docetaxel Injection

breast, lung, prostate, stomach, and head/neck cancer

2

Enzalutamide SG Capsules

Treat prostate cancer

3

Epirubicin Injection

Treat breast cancer

4

Erlotinib Tablets

Treat lung and pancreatic cancer

5

Fulvestrant Injection

advanced breast cancer

6

Irinotecan Injection

Treat colon or rectal cancer 

7

Melphalan Dry Vial – Lyo BP

Treat multiple myeloma and ovarian cancer

8

Oxaliplatin Injection

Treat advanced colon or rectal cancer

9

Paclitaxel injection

Treat various types of cancer

10

Palbociclib Capsules IH

Treat a certain type of hormone receptor–positive, advanced breast cancer 

11

Pazopanib HCl Tablets

Treat kidney cancer

12

Pemetrexed Disodium for Injection Dry Vial

Treat advanced or metastatic nonsquamous non-small cell lung cancer

13

TemoZolomide Capsules

Treatcertain types of brain tumors

14

Tamoxifen

breast cancer

15

Gemcitabine

type of lung cancer (non-small cell lung cancer; NSCLC)

16

Doxorubicin Injection

treat certain types of bladder, breast, lung, stomach, and ovarian cancer; Hodgkin’s lymphoma